Trial intelligence / Profile preview

Methadone for chronic cough in cancer patients receiving palliative care

ACTRN12616001061426Phase 4Not yet recruiting

Sponsor
Monash Health
Start
Sep 2016
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 4, randomised, double-blind trial of methadone in chronic cough (2 arms), sponsored by Monash Health. Primary endpoints: Clinically significant reduction in cough and Improvement in quality of life related to cough. Planned start Sep 2016; status: not yet recruiting.

02

Drugs

methadone
03

Conditions

chronic cough

Beyond the preview

Go deeper on ACTRN12616001061426.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ACTRN12616001061426.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call